Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial)

American Journal of Cardiology

Volumn 95, Issue 4, 2005, Pages 529-532

  Majahalme, Silja K ^a   Baruch, Lawrence ^b   Aknay, Nora ^b   Goedel Meinen, Liselotte ^b   Hofmann, Monika ^b   Hester, Allen ^b   Prescott, Margaret Forney ^b   Feliciano, Nancy ^b  

^a Appleton Heart Institute   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VALSARTAN;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE; TREATMENT OUTCOME;

EID: 13844296683     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.10.026     Document Type: Article

References (14)

1. J.N. Cohn, G. Tognoni Valsartan Heart Failure Trial Investigators A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 2001 1667 1675
2. M. Wong, L. Staszewsky, R. Latini, S. Barlera, A. Volpi, Y.T. Chiang, R.L. Benza, S.O. Gottlieb, T.D. Kleemann, F. Rosconi Val-HeFT Heart Failure Trial Investigators Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT Echocardiographic Study J Am Coll Cardiol 40 2002 970 975
3. R. Latini, S. Masson, I. Anand, D. Judd, A.P. Maggioni, Y.T. Chiang, M. Bevilacqua, M. Salio, P. Cardano, P.H. Dunselman Val-HeFT Investigators Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT) Circulation 106 2002 2454 2458
4. J.N. Cohn, I.S. Anand, R. Latini, S. Masson, Y.T. Chiang, R. Glazer Valsartan Heart Failure Trial Investigators Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial Circulation 108 2003 1306 1309
5. J.N. Cohn, G. Tognoni, R. Glazer, D. Spormann, A. Hester Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic heart failure J Card Fail 5 1999 155 160
6. J.N. Cohn, G. Tognoni, R. Glazer, D. Spormann Val-HeFT Investigators Baseline demographics of the Valsartan Heart Failure Trial Eur J Heart Fail 2 2000 439 446
7. D. Levy, S. Kenchaiah, M.G. Larson, E.J. Benjamin, M.J. Kupka, K.K. Ho, J.M. Murabito, R.S. Vasan Long-term trends in the incidence of and survival with heart failure N Engl J Med 347 2002 1397 1402
8. C. Opasich, L. Tavazzi, D. Lucci, M. Gorini, M.C. Albanese, G. Cacciatore, A.P. Maggioni on behalf of the Italian Network on Chronic Heart Failure (IN-HF) Investigators Comparison of one-year outcome in women versus men with chronic heart failure Am J Cardiol 86 2000 353 357
9. M. Martinez-Selles, J.A. Garcia Robles, L. Prieto, M. Dominguez Munoa, E. Frades, O. Diaz-Castro, J. Almendral Systolic dysfunction is a predictor of long term mortality in men but not in women with heart failure Eur Heart J 24 2003 2046 2053
10. L.A. Mendes, R. Davidoff, L.A. Cupples, T.J. Ryan, A.K. Jacobs Congestive heart failure in patients with coronary artery disease: the gender paradox Am Heart J 134 1997 207 211
11. E. Gerdts, M. Zabalgoitia, H. Björnstad, T.L. Svendson, R.B. Devereux Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study) Am J Cardiol 87 2001 980 983
12. Y. Liao, R.S. Cooper, G.A. Mensah, D.L. McGee Left ventricular hypertrophy has a greater impact on survival in women than in men Circulation 92 1995 805 810
13. J.D. Carroll, E.P. Carroll, T. Feldman, D.M. Ward, R.M. Lang, D. McGaughey, R.B. Karp Sex-associated differences in left ventricular function in aortic stenosis of the elderly Circulation 86 1992 1099 1107
14. D. Levy, M.G. Larson, R.S. Vasan, W.B. Kannel, K.K. Ho The progression from hypertension to congestive heart failure JAMA 275 1996 1557 1562